R. Valente

1.8k total citations
25 papers, 1.3k citations indexed

About

R. Valente is a scholar working on Rheumatology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, R. Valente has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 10 papers in Pathology and Forensic Medicine and 7 papers in Genetics. Recurrent topics in R. Valente's work include Rheumatoid Arthritis Research and Therapies (10 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). R. Valente is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (10 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). R. Valente collaborates with scholars based in United States, Argentina and Germany. R. Valente's co-authors include Gustavo Citera, Michael E. Weinblatt, Michael A. Maldonado, Roy Fleischmann, Michael Schiff, Désirée van der Heijde, Ayanbola Elegbe, Cathy Zhao, John L. Niles and Gary S. Hoffman and has published in prestigious journals such as PLoS ONE, Clinical Orthopaedics and Related Research and Annals of the Rheumatic Diseases.

In The Last Decade

R. Valente

23 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Valente United States 14 828 346 323 307 289 25 1.3k
Luis Carreño Spain 20 1.4k 1.7× 293 0.8× 353 1.1× 574 1.9× 358 1.2× 69 2.2k
E. L. Matteson United States 19 967 1.2× 683 2.0× 168 0.5× 161 0.5× 228 0.8× 36 1.6k
Hayato Nagasawa Japan 19 792 1.0× 176 0.5× 250 0.8× 193 0.6× 213 0.7× 51 1.1k
Loukas Settas Greece 16 819 1.0× 144 0.4× 358 1.1× 349 1.1× 134 0.5× 28 1.2k
H Kritikos Greece 16 693 0.8× 132 0.4× 253 0.8× 511 1.7× 268 0.9× 23 1.5k
Colin Pease United Kingdom 24 2.2k 2.6× 816 2.4× 416 1.3× 440 1.4× 430 1.5× 33 2.8k
David M. Menke United States 24 556 0.7× 370 1.1× 224 0.7× 254 0.8× 309 1.1× 93 2.2k
Leonor Barile-Fabris Mexico 13 815 1.0× 116 0.3× 145 0.4× 415 1.4× 111 0.4× 30 1.2k
Md Yuzaiful Md Yusof United Kingdom 17 700 0.8× 239 0.7× 90 0.3× 535 1.7× 118 0.4× 65 1.2k
Stefania Sacco Italy 13 502 0.6× 69 0.2× 176 0.5× 264 0.9× 211 0.7× 20 958

Countries citing papers authored by R. Valente

Since Specialization
Citations

This map shows the geographic impact of R. Valente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Valente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Valente more than expected).

Fields of papers citing papers by R. Valente

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Valente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Valente. The network helps show where R. Valente may publish in the future.

Co-authorship network of co-authors of R. Valente

This figure shows the co-authorship network connecting the top 25 collaborators of R. Valente. A scholar is included among the top collaborators of R. Valente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Valente. R. Valente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Genovese, Mark C., César Pacheco‐Tena, Eduardo Mysler, et al.. (2018). Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial. The Journal of Rheumatology. 45(8). 1085–1092. 21 indexed citations
2.
3.
Weinblatt, Michael E., Michael Schiff, R. Valente, et al.. (2014). 86. Head-to-Head Comparison of Subcutaneous Abatacept Versus Adalimumab on Background Methotrexate in Rheumatoid Arthritis: Blinded Two-Year Results from the Ample Study. Lara D. Veeken. 53(suppl_1). i88–i88. 1 indexed citations
4.
Schiff, Michael, Michael E. Weinblatt, R. Valente, et al.. (2013). Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial. Annals of the Rheumatic Diseases. 73(1). 86–94. 208 indexed citations
5.
Schiff, Michael, Michael E. Weinblatt, R. Valente, et al.. (2013). OP0044 Head-To-Head Comparison of Subcutaneous Abatacept Versus Adalimumab on Background Methotrexate in RA: Two Year Results from the Ample Study. Annals of the Rheumatic Diseases. 72. A64–A64. 5 indexed citations
6.
Choy, Ernest, Frank McKenna, Jiří Vencovský, et al.. (2012). Certolizumab pegol plus MTX administered every 4 weeks is effective in patients with RA who are partial responders to MTX. Lara D. Veeken. 51(7). 1226–1234. 67 indexed citations
7.
Weinblatt, Michael E., Michael Schiff, R. Valente, et al.. (2012). Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study. Arthritis & Rheumatism. 65(1). 28–38. 189 indexed citations
8.
Valente, R., et al.. (2012). Toll-Like Receptor 7 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1. PLoS ONE. 7(8). e43317–e43317. 30 indexed citations
9.
Fleischmann, Roy, Michael E. Weinblatt, R. Valente, et al.. (2012). OP0022 Abatacept sc versus adalimumab on background methotrexate in RA: One year results from the ample study. Annals of the Rheumatic Diseases. 71. 60–60. 13 indexed citations
10.
Genovese, M. C., G. Léon, Eduardo Mysler, et al.. (2012). FRI0193 SC vs IV abatacept in RA: post-hoc efficacy analysis of long-term acquire (SC) data with aim (IV) data. Annals of the Rheumatic Diseases. 71. 378–378. 2 indexed citations
11.
Léon, G., Eduardo Mysler, M. Keiserman, et al.. (2011). Subcutaneous abatacept versus intravenous abatacept: A phase IIIb noninferiority study in patients with an inadequate response to methotrexate. Arthritis & Rheumatism. 63(10). 2854–2864. 155 indexed citations
12.
Payne, Jeffrey B., Julie A. Stoner, Pirkka V. Nummikoski, et al.. (2007). Subantimicrobial dose doxycycline effects on alveolar bone loss in post‐menopausal women. Journal Of Clinical Periodontology. 34(9). 776–787. 37 indexed citations
13.
Goronzy, Jörg J., Eric L. Matteson, James W. Fulbright, et al.. (2004). Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis & Rheumatism. 50(1). 43–54. 138 indexed citations
14.
Stone, John H., Gary S. Hoffman, Peter A. Merkel, et al.. (2001). A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score. Arthritis & Rheumatism. 44(4). 912–920. 352 indexed citations
15.
Valente, R., et al.. (1999). A Commonsense Approach to Shoulder Problems. Mayo Clinic Proceedings. 74(8). 785–794. 21 indexed citations
16.
Valente, R. & Doyt L. Conn. (1994). Current Therapies for Systemic Vasculitis. Seminars in Neurology. 14(4). 380–386. 13 indexed citations
17.
Valente, R. & H Gibson. (1994). Chiropractic manipulation in carpal tunnel syndrome.. PubMed. 17(4). 246–9. 21 indexed citations
18.
Kitaoka, Harold B., et al.. (1994). Foot and Ankle Surgery in Patients With Psoriasis. Clinical Orthopaedics and Related Research. 300(300). 201???206–201???206. 14 indexed citations
19.
McCarthy, James T., Philip J. Dahlberg, J. Scott Kriegshauser, et al.. (1988). Erosive Spondyloarthropathy in Long-Term Dialysis Patients: Relationship to Severe Hyperparathyroidism. Mayo Clinic Proceedings. 63(5). 446–452. 25 indexed citations
20.
Perego, Silvia, et al.. (1980). L'Ecotomografia Transrettale Nello «Staging» Del Carcinoma Prostatico. Urologia Journal. 47(4). 739–742.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luis Carreño Breakdown of academic impact, for papers by E. L. Matteson Breakdown of academic impact, for papers by Hayato Nagasawa Breakdown of academic impact, for papers by Loukas Settas Breakdown of academic impact, for papers by H Kritikos Breakdown of academic impact, for papers by Colin Pease Breakdown of academic impact, for papers by David M. Menke Breakdown of academic impact, for papers by Leonor Barile-Fabris Breakdown of academic impact, for papers by Md Yuzaiful Md Yusof Breakdown of academic impact, for papers by Stefania Sacco
Rankless by CCL
2026